Calyx Consulting

“An investment in knowledge pays the best interest.”
- Benjamin Franklin

Put Calyx’s experience to work for you.

Calyx is an industry leader in delivering the solutions pharmaceutical companies and Clinical Research Organizations (CROs) need to:

  • Improve the reliability of data when imaging biomarkers are used in clinical trials
  • Optimize randomization and trial supply management so trials run effectively
  • Ensure worldwide regulatory requirements are met, every time

Having supported over 650 new drug approvals, Calyx scientific, technical, and regulatory experts possess a depth and diversity of experience that’s unmatched and are prepared for whatever the drug development and regulatory compliance process throws at them.  Contact us now to learn how Calyx consultants can help you meet your development objectives and pave your way to success.

Meet the experts.

Extend the deep and diverse experience of Calyx’s highly tenured scientific, technical, and regulatory experts to your own clinical development team.

Minimize risks in clinical trial imaging, RTSM, and regulatory information management. Contact us today.

Library

Supporting Accelerated Approval of Novel Bladder Cancer Treatment

Learn how an emerging biotech company turned to Calyx medical imaging when their other providers couldn't manage the complexity of their protocols.
Read more

Calyx IRT: Ensuring Trial Supply through Unexpected Study Changes

Calyx IRT was the system of choice for a study involving patients admitted in intensive care units (ICU) due to complications linked to COVID-19 infection.
Read more

LG Chem Randomization Challenge Resolved by Calyx IRT

One of Calyx’s randomization experts was engaged in discussions with LG Chem during the IRT vendor selection process and throughout the study setup phase.
Read more

Medical Imaging in Rare Disease Trials: Hypertrophic Obstructive Cardiomyopathy (HOCM)

Clinical trial sponsors face many challenges when medical imaging is used to evaluate the safety and efficacy of new medical treatments.
Read more